scholarly journals Health-Related Quality of Life of Food-Insecure Ethnic Minority Patients With Cancer

2015 ◽  
Vol 11 (5) ◽  
pp. 396-402 ◽  
Author(s):  
Francesca Gany ◽  
Jennifer Leng ◽  
Julia Ramirez ◽  
Serena Phillips ◽  
Abraham Aragones ◽  
...  

Underserved racial/ethnic minority patients diagnosed with cancer are a vulnerable patient population, and at significant risk for inadequate food.

2021 ◽  
Vol 5 (1) ◽  
Author(s):  
Dana Drzayich Antol ◽  
Adrianne Waldman Casebeer ◽  
Raya Khoury ◽  
Todd Michael ◽  
Andrew Renda ◽  
...  

An amendment to this paper has been published and can be accessed via the original article.


2003 ◽  
Vol 1 (1) ◽  
pp. 49-54 ◽  
Author(s):  
Robert E. Smith ◽  
John A. Glaspy ◽  
N. Simon Tchekmedyian ◽  
Matthew D. Austin ◽  
Joel D. Kallich

2008 ◽  
Vol 36 (5) ◽  
pp. 488-496 ◽  
Author(s):  
Deepa Rao ◽  
Scott Debb ◽  
David Blitz ◽  
Seung W. Choi ◽  
David Cella

10.2196/19694 ◽  
2020 ◽  
Vol 22 (9) ◽  
pp. e19694
Author(s):  
François-Emery Cotté ◽  
Paméla Voillot ◽  
Bryan Bennett ◽  
Bruno Falissard ◽  
Christophe Tzourio ◽  
...  

Background Immune checkpoint inhibitors (ICIs) are increasingly used to treat several types of tumors. Impact of this emerging therapy on patients’ health-related quality of life (HRQoL) is usually collected in clinical trials through standard questionnaires. However, this might not fully reflect HRQoL of patients under real-world conditions. In parallel, users’ narratives from social media represent a potential new source of research concerning HRQoL. Objective The aim of this study is to assess and compare coverage of ICI-treated patients’ HRQoL domains and subdomains in standard questionnaires from clinical trials and in real-world setting from social media posts. Methods A retrospective study was carried out by collecting social media posts in French language written by internet users mentioning their experiences with ICIs between January 2011 and August 2018. Automatic and manual extractions were implemented to create a corpus where domains and subdomains of HRQoL were classified. These annotations were compared with domains covered by 2 standard HRQoL questionnaires, the EORTC QLQ-C30 and the FACT-G. Results We identified 150 users who described their own experience with ICI (89/150, 59.3%) or that of their relative (61/150, 40.7%), with 137 users (91.3%) reporting at least one HRQoL domain in their social media posts. A total of 8 domains and 42 subdomains of HRQoL were identified: Global health (1 subdomain; 115 patients), Symptoms (13; 76), Emotional state (10; 49), Role (7; 22), Physical activity (4; 13), Professional situation (3; 9), Cognitive state (2; 2), and Social state (2; 2). The QLQ-C30 showed a wider global coverage of social media HRQoL subdomains than the FACT-G, 45% (19/42) and 29% (12/42), respectively. For both QLQ-C30 and FACT-G questionnaires, coverage rates were particularly suboptimal for Symptoms (68/123, 55.3% and 72/123, 58.5%, respectively), Emotional state (7/49, 14% and 24/49, 49%, respectively), and Role (17/22, 77% and 15/22, 68%, respectively). Conclusions Many patients with cancer are using social media to share their experiences with immunotherapy. Collecting and analyzing their spontaneous narratives are helpful to capture and understand their HRQoL in real-world setting. New measures of HRQoL are needed to provide more in-depth evaluation of Symptoms, Emotional state, and Role among patients with cancer treated with immunotherapy.


2018 ◽  
Vol 36 (23) ◽  
pp. 2413-2421 ◽  
Author(s):  
Félix Compen ◽  
Else Bisseling ◽  
Melanie Schellekens ◽  
Rogier Donders ◽  
Linda Carlson ◽  
...  

Purpose Mindfulness-based cognitive therapy (MBCT) has been shown to alleviate psychological distress in patients with cancer. However, patients experience barriers to participating in face-to-face MBCT. Individual Internet-based MBCT (eMBCT) could be an alternative. The study aim was to compare MBCT and eMBCT with treatment as usual (TAU) for psychological distress in patients with cancer. Patients and Methods We obtained ethical and safety approval to include 245 patients with cancer with psychological distress (≥ 11 on the Hospital Anxiety and Depression Scale) in the study. They were randomly allocated to MBCT (n = 77), eMBCT (n = 90), or TAU (n = 78). Patients completed baseline (T0) and postintervention (T1) assessments. The primary outcome was psychological distress on the Hospital Anxiety and Depression Scale. Secondary outcomes were psychiatric diagnosis, fear of cancer recurrence, rumination, health-related quality of life, mindfulness skills, and positive mental health. Continuous outcomes were analyzed using linear mixed modeling on the intention-to-treat sample. Because both interventions were compared with TAU, the type I error rate was set at P < .025. Results Compared with TAU, patients reported significantly less psychological distress after both MBCT (Cohen’s d, .45; P < .001) and eMBCT (Cohen’s d, .71; P < .001) . In addition, post-treatment prevalence of psychiatric diagnosis was lower with both MBCT (33% improvement; P = .030) and eMBCT (29% improvement; P = .076) in comparison with TAU (16%), but these changes were not statistically significant. Both interventions reduced fear of cancer recurrence and rumination, and increased mental health–related quality of life, mindfulness skills, and positive mental health compared with TAU (all Ps < .025). Physical health–related quality of life did not improve ( P = .343). Conclusion Compared with TAU, MBCT and eMBCT were similarly effective in reducing psychological distress in a sample of distressed heterogeneous patients with cancer.


2019 ◽  
Vol 28 (7) ◽  
pp. 1761-1771 ◽  
Author(s):  
Jan L. Wallander ◽  
Chris Fradkin ◽  
Marc N. Elliott ◽  
Paula M. Cuccaro ◽  
Susan Tortolero Emery ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document